Your browser doesn't support javascript.
loading
Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor Therapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Study from a Single-Center.
Kong, Fan-Cong; Qi, Ling; Zhou, Yu-Lan; Yu, Min; Huang, Wen-Feng; Li, Fei.
Affiliation
  • Kong FC; Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
  • Qi L; Jiangxi Clinical Research Center for Hematologic Diseases, Nanchang, 330006, China.
  • Zhou YL; Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
  • Yu M; Jiangxi Clinical Research Center for Hematologic Diseases, Nanchang, 330006, China.
  • Huang WF; Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
  • Li F; Jiangxi Clinical Research Center for Hematologic Diseases, Nanchang, 330006, China.
Curr Med Sci ; 43(6): 1151-1161, 2023 Dec.
Article in En | MEDLINE | ID: mdl-38057538
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine Limits: Humans Language: En Journal: Curr Med Sci Year: 2023 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine Limits: Humans Language: En Journal: Curr Med Sci Year: 2023 Document type: Article Affiliation country: China Country of publication: China